Human Germline Manipuation and Cloning as Women's Issues
By Marcy Darnovsky,
GeneWatch
| 06. 30. 2001
While the prospect of genetically "redesigned" people challenges humanity as a whole, it particularly threatens groups that historically have been disempowered. And because human germline engineering and cloning are so closely tied to reproduction, they are of special concern to women.
The New Eugenics and the Commercialization of Reproduction
Already, prenatal screening and preimplantation diagnosis make it possible to eliminate fetuses and embryos with a number of identifiable genetic conditions. As disability rights activists point out, these developments put women in the position of "eugenic gatekeepers." Inheritable genetic modification, to whatever extent it turns out to be technically possible, would amplify the powers of eugenic selection many times over.
If a new "free-market eugenics" were to take hold, who would actually exercise "consumer preference" for genetic "enhancements?" Who would decide what was on offer?
Human cloning and germline engineering would move decisions about reproduction further away from women, not only toward doctors and technicians but also toward marketers proffering the "enhancements" developed by biotech companies. Women could find themselves simultaneously losing ever more control of their own childbearing experiences, and...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...